Leerink Partners on Arrowhead Pharma (ARWR): SRPT data drives shares up despite IONS pricing update
Tweet Send to a Friend
Leerink Partners analyst Mani Foroohar reiterated a Market Perform rating and $61.00 price target on Arrowhead Pharma (NASDAQ: ARWR)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
